Nebivolol, a beta adrenergic receptor antagonist blocks angiotensin II-mediated signaling in heart [abstract]
![[PDF]](/xmlui/themes/Mirage2//images/mimes_sm/pdf.png "PDF file"){kind=small}
NebivololBetaAdrenergic.pdf (223.9Kb)Abstract
We recently showed that Nebivolol, a β-adrenergic receptor (AR) antagonist attenuates myocardial oxidative stress and promotes insulin metabolic signaling in 9 week old Zucker obese (ZO) insulin resistant rats. Here, we demonstrate that Nebivolol suppresses angiotensin II type I receptor (AT1R)-mediated signaling in ZO hearts as well as in HL-1 cardiomyocytes.